Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

Last updated on 2017-06-15 History
Report ID 1184
Drug Identification Number 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name Levofloxacin
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 250mg / 50mL x 24 & 500mg/100mL x 24 & 750mg/150mL x24
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-11-09
Estimated end date 2017-06-14
Actual end date 2017-06-14
Shortage status Resolved
Updated date 2017-06-15
Company comments Resolved June 14, 2017
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-06-15 English Compare
v8 2017-06-14 French Compare
v7 2017-06-14 English Compare
v6 2017-06-05 French Compare
v5 2017-06-05 English Compare
v4 2017-05-05 French Compare
v3 2017-05-05 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare